Risk factors predict microscopic extranodal tumor deposits in advanced stage III colon cancer patients

被引:4
|
作者
Jhuang, Yi-Han [1 ]
Chou, Yu-Ching [2 ]
Lin, Yu-Chun [3 ]
Hu, Je-Ming [4 ]
Pu, Ta-Wei [5 ]
Chen, Chao-Yang [4 ]
机构
[1] Natl Def Med Ctr, Triserv Gen Hosp, Div Cardiovasc Surg, Taipei 114, Taiwan
[2] Natl Def Med Ctr, Sch Publ Hlth, Taipei 114, Taiwan
[3] Natl Def Med Ctr, Triserv Gen Hosp, Dept Pathol, Taipei 114, Taiwan
[4] Natl Def Med Ctr, Triserv Gen Hosp, Div Colorectal Surg, 325 Chang Gong Rd, Taipei 114, Taiwan
[5] Natl Def Med Ctr, Triserv Gen Hosp, Div Colorectal Surg, Song Shan Branch, Taipei 114, Taiwan
关键词
Colon cancer; Tumor deposits; Lymphovascular invasion; Risk factor; COLORECTAL-CANCER; METASTASES; INVASION; IMPACT;
D O I
10.3748/wjg.v29.i11.1735
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUNDColorectal cancer is a frequent cause of cancer-related mortality in patients with lymph node or distant metastases. Pericolonic tumor deposits (TDs) are considered prognostically distinct from lymph node metastases.AIMTo investigate risk factors for extranodal TDs in stage III colon cancer.METHODSThis was a retrospective cohort study. We selected 155 individuals diagnosed with stage III colon cancer from the database of the Cancer Registry of the Tri-Service General Hospital. The patients were allocated into the groups with/without N1c. Multivariate Cox regression analysis and Kaplan-Meier method were done. The primary outcomes investigate the association between the covariates and extranodal TDs, and prognostic significance of the covariates regarding the survival.RESULTSThere were 136 individuals in the non-N1c group and 19 individuals in the N1c group. Patients with lymphovascular invasion (LVI) had a higher risk of TDs. Overall survival rates of patients with and without LVI were 6.64 years and 8.61 years, respectively (P = 0.027). The N1c patients without LVI had higher overall survival than those who with LVI (7.73 years vs 4.42 years, P = 0.010).CONCLUSIONPatients having stage III colon cancer with LVI have a higher probability of having TDs than those with stage III colon cancer without LVI. Stage III colon cancer patients with TDs and LVI could have poor prognosis and outcome.
引用
收藏
页码:1735 / 1744
页数:10
相关论文
共 50 条
  • [21] Polymorphisms in VEGF and IL-8 predict tumor recurrence in stage III colon cancer
    Lurje, G.
    Zhang, W.
    Schultheis, A. M.
    Yang, D.
    Groshen, S.
    Hendifar, A. E.
    Husain, H.
    Gordon, M. A.
    Nagashima, F.
    Chang, H. M.
    Lenz, H. -J.
    ANNALS OF ONCOLOGY, 2008, 19 (10) : 1734 - 1741
  • [22] AJCC nodal factors and microscopic tumor burden predict recurrence in sentinel lymph node positive stage III melanoma patients
    Andtbacka, RH
    Bedrosian, I
    Ross, MJ
    Lin, E
    Prieto, VG
    Aloia, TA
    Cormier, JN
    Lee, JE
    Mansfield, PF
    Gershenwald, JE
    ANNALS OF SURGICAL ONCOLOGY, 2006, 13 (02) : 12 - 12
  • [23] Stage I-III colon cancer patients with tumor deposits behave similarly to stage IV patients. Cross-section analysis of 392 patients
    Lino-Silva, Leonardo S.
    Anchondo-Nunez, Patricia
    Chit-Huerta, Alonso
    Aguilar-Romero, Estefania
    Morales-Soto, Jonathan
    Salazar-Garcia, Jenny A.
    Guzman-Lopez, Cristina J.
    Maldonado-Martinez, Hector A.
    Meneses-Garcia, Abelardo
    Salcedo-Hernandez, Rosa A.
    JOURNAL OF SURGICAL ONCOLOGY, 2019, 120 (02) : 300 - 307
  • [24] Novel Model to Predict the Prognosis of Patients with Stage II-III Colon Cancer
    Xu, Yansong
    Liang, Fangfang
    Chen, Yi
    Wang, Zhen
    Zhong, Huage
    Tang, Weizhong
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [25] Prognostic value of tumor laterality and recurrence risk in patients with stage III colon cancer treated with adjuvant chemotherapy
    Monteiro, A.
    Cunha Pereira, T.
    Felix Soares, R.
    Macedo, F.
    Paulo, J.
    Marques, M.
    Bonito, N.
    Jacinto, P.
    Ribeiro, J.
    Sousa, G.
    ANNALS OF ONCOLOGY, 2020, 31 : S101 - S101
  • [26] Prognostic value of tumor deposits in stage III colon cancer patients, a post-hoc analysis of CALGB/SWOG 80702 phase III study
    Cohen, Romain
    Shi, Qian
    Meyers, Jeffrey P.
    Jin, Zhaohui
    Svrcek, Magali
    Fuchs, Charles S.
    Couture, Felix
    Kuebler, Phillip J.
    Bendell, Johanna C.
    De Jesus-Acosta, Ana
    Kumar, Pankaj
    Lewis, DeQuincy Andrew
    Tan, Benjamin R.
    Bertagnolli, Monica M.
    Hochster, Howard S.
    Blanke, Charles David
    O'Reilly, Eileen Mary
    Shields, Anthony Frank
    Meyerhardt, Jeffrey A.
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (03)
  • [27] Tumor microsatellite-instability status to predict benefit of adjuvant chemotherapy for stage III colon cancer
    Chang, G. J.
    Lee, K. Y.
    Eng, C.
    Kattepogu, K. M.
    Richey, S.
    Skibber, J. M.
    Rodriguez-Bigas, M. A.
    Hamilton, S. R.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [28] Aussagekraft von Tumordeposits bei Patienten mit Kolonkarzinom im Stadium IIIImportance of tumor deposits in patients with stage III colon cancer
    M. Schrempf
    Matthias Anthuber
    Der Chirurg, 2020, 91 (9): : 781 - 781
  • [29] Prognostic factors for stage III colon cancer in patients 80 years of age and older
    Bogdan Badic
    Maude Oguer
    Melanie Cariou
    Tiphaine Kermarrec
    Servane Bouzeloc
    Jean-Baptiste Nousbaum
    Michel Robaszkiewicz
    Lucille Queneherve
    International Journal of Colorectal Disease, 2021, 36 : 811 - 819
  • [30] Prognostic factors for stage III colon cancer in patients 80 years of age and older
    Badic, Bogdan
    Oguer, Maude
    Cariou, Melanie
    Kermarrec, Tiphaine
    Bouzeloc, Servane
    Nousbaum, Jean-Baptiste
    Robaszkiewicz, Michel
    Queneherve, Lucille
    INTERNATIONAL JOURNAL OF COLORECTAL DISEASE, 2021, 36 (04) : 811 - 819